Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Exercise/Conversion of 1,635 FDMT shares, $6.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 1,635 | $6.8K |
| Sep 3, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 584 | $3.8K |
| Aug 17, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 1,635 | $6.8K |
| Jul 2, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 814 | $3.4K |
| Jun 25, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 9,810 | $40.6K |
| Mar 27, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 217,000 | n/a |
| Dec 19, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 1,635 | $6.8K |
| Nov 20, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 1,635 | $6.8K |
| Oct 27, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 1,084 | $7.0K |
| Oct 20, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 1,635 | $6.8K |